首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

2011929

全球周邊血管器械市場：按類型、按最終用戶分類 - 預測（至 2031 年）

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031

出版日期: 2026年02月16日 | 出版商:

MarketsandMarkets | 英文 453 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計到 2031 年，全球周邊血管器械市場規模將達到 132.2 億美元，高於 2026 年的 100.2 億美元，2026 年至 2031 年的複合年成長率為 5.7%。

調查範圍
調查期	2024-2031
基準年	2025
預測期	2026-2031
單元	10億美元，1000/100萬單位
部分	類型、最終使用者、區域
目標區域	北美、歐洲、亞太地區、拉丁美洲、中東和非洲

由於周邊動脈疾病(PAD) 和其他血管疾病的盛行率不斷上升，周邊血管器械市場呈現顯著成長。這些疾病與人口老化以及糖尿病、肥胖和吸菸率的上升密切相關。微創血管內器械的創新，例如藥物塗層球囊、新一代支架、動脈粥狀硬化斑塊切除術系統和栓塞保護裝置，顯著改善了臨床療效，並擴大了可治療的患者範圍。此外，許多地區優惠的報銷政策，以及人們越來越傾向於在門診和門診手術中心進行手術，都在加速這些器械的普及應用。

此外，人們對早期診斷和治療的認知不斷提高，開發中國家醫療基礎設施的改善，以及主要製造商對創新和臨床研究的持續投資，都促進了市場成長。

“在血管成形術用氣球市場中，傳統/標準球囊細分市場預計在預測期內將以最高的複合年成長率成長。”

在血管成形術用氣球市場，由於其成本效益高、臨床應用廣泛以及在周圍血管和冠狀動脈介入治療中的多功能性，普通（標準）球囊的需求正在成長。這些球囊仍廣泛用於病變預備以及擴張前後的操作，尤其是在不需要或保險不涵蓋藥物釋放型球囊的情況下。儘管出現了先進的球囊技術，但由於其易用性、可靠性以及與各種支架系統的兼容性，標準球囊在低需求、高銷量的市場（尤其是在開發中國家）仍然保持著強勁的銷售勢頭。

“在動態血流調節裝置市場中，栓塞保護裝置細分市場預計在預測期內將以最高的複合年成長率成長。”

在動態血流調節裝置市場，栓塞保護裝置的需求預計將會成長。這是因為這類裝置在複雜的血管內治療和結構性心臟疾病治療中的應用日益廣泛，而這些治療中遠端栓塞的風險顯著較高。尤其值得注意的是，人們對頸動脈、周邊血管和經導管介入治療中中風和器官缺血等手術相關併發症的認知不斷提高，正在加速臨床應用。此外，裝置設計的改進，例如提高捕獲效率、輸送效率和血管相容性，也顯著推動了市場成長。相關指引的發展和微創血管外科手術的普及進一步強化了這一趨勢。

“按終端用戶細分市場來看，在預測期內，門診手術中心 (ASC) 細分市場在周圍血管器械市場中的複合年成長率預計將最高。”

周邊血管器械市場正經歷顯著成長，這主要得益於門診手術中心（ASC）的正面影響。這些中心正在推動微創手術的普及，並將門診環境下的舒適性和安全性放在首位。門診手術中心具有許多優勢，包括降低手術成本、提高患者周轉率、縮短住院時間以及提升營運效率，使其成為保險公司、醫療服務提供者和患者的理想選擇。周邊血管器械的創新，例如微型影像系統、Low profile導管、球囊和動脈粥狀硬化斑塊切除術裝置，使得即使是最複雜的手術也能在門診手術中心進行。此外，優惠的報銷政策、醫生自主運作模式、越來越多的患者希望當天出院以及周邊動脈疾病（PAD）發病率的上升，都促進了門診手術中心在該市場的快速普及。

本報告對全球周邊血管器材市場進行了深入分析，深入探討了關鍵促進因素和限制因素、產品開發和創新以及競爭格局。

波特五力分析
總體經濟指標
- GDP趨勢與預測
- 全球醫療產業的趨勢
- 全球醫療設備業趨勢
供應鏈分析
價值鏈分析
生態系分析
定價分析
- 主要企業產品平均售價趨勢（2023-2025 年）
- 各地區平均產品售價趨勢（2023-2025 年）
貿易分析
- HS編碼901839的進口數據
- HS編碼901839的出口數據
重大會議和活動（2026-2027）
影響客戶業務的趨勢/干擾因素
投資和資金籌措場景
案例研究分析
- MEDTRONIC
- TERUMO
- BOSTON SCIENTIFIC CORPORATION
2025年美國關稅對周邊血管器械市場的影響
- 主要關稅稅率
- 價格影響分析
- 國家/地區
- 對終端用戶產業的影響

第6章：技術進步、人工智慧的影響、專利、創新與未來應用

技術分析
- 主要新技術
- 互補技術
- 鄰近技術
技術/產品藍圖
專利分析
- 周邊血管器械市場專利公開趨勢、主要申請人及司法管轄區分析（2015年1月至2025年12月）
- 主要專利清單（2023-2026）
未來用途
- 血管內碎石術治療鈣化脂肪組織病變
- 先進的影像引導介入
- 智慧型感測器整合血管植入
- 綜合性多功能血管內裝置
人工智慧對周邊血管器械市場的影響

第7章監理環境與永續性舉措

監理與合規
- 監管機構、政府機構和其他組織
- 業界標準
對永續性的承諾
- 永續包裝和數位化說明（以波士頓科學公司案例研究）
- 永續產品生命週期管理（雅培案例研究）
- 美敦力公司為減少包裝廢棄物所做的努力
認證、標籤檢視、環境標準

第8章：顧客趨勢與購買行為

決策流程
採購過程中的關鍵相關利益者及其評估標準
- 採購過程中的關鍵相關利益者
- 購買標準
招募障礙和內部挑戰
各種終端使用者環境中的未滿足需求
市場盈利
- 轉向高附加價值產品、藥物釋放型特性和專用醫療設備。
- 人口老化和周邊動脈疾病的盛行率正在推動手術數量的增加。
- 透過提高供應鏈效率和擴大產品組合來最佳化成本。

第9章周邊血管器械市場：按類型分類

血管成形術支架市場：依類型分類
- 定量分析：血管成形術支架市場（按類型分類）
- 藥物釋放型支架
- 裸金屬支架
血管內動脈瘤修復血管支架市場：按類型分類
- 腹部主動脈血管瘤血管支架
- 胸主動脈瘤血管支架
導管市場：依類型分類
- 血管造影術導管
- 引導管
- IVUS/OCT導管
下腔靜脈濾器市場：按類型分類
- 可回收過濾器
- 永久過濾器
血管成形術用氣球市場：依類型分類
- 舊式/標準氣球
- 藥物釋放型球囊
- 切割球囊導管
斑塊改良設備市場：依類型分類
- 動脈粥狀硬化斑塊切除術裝置
- 血栓除去裝置
動態血液流動調節裝置市場：按類型分類
- 栓塞保護裝置
- 慢性完全閉塞裝置
其他周邊血管器械市場：按類型分類
- 導管導引線
- 血管閉合裝置
- 導引鞘
- 氣球膨脹裝置

第10章周邊血管器械市場：依最終用戶分類

醫院
門診手術中心
其他最終用戶

第11章周邊血管器械市場：依地區分類

北美洲
- 北美宏觀經濟展望
- 北美血管成形術支架市場：按類型分類的銷售分析
- 美國
- 加拿大
歐洲
- 歐洲宏觀經濟展望
- 歐洲血管成形術支架市場：按類型分類的銷售分析
- 德國
- 法國
- 英國
- 西班牙
- 義大利
- 其他歐洲國家
亞太地區
- 亞太地區宏觀經濟展望
- 亞太地區血管成形術支架市場，銷售分析：依類型分類
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太其他地區
拉丁美洲
- 拉丁美洲宏觀經濟展望
- 拉丁美洲血管成形術支架市場：按類型分類的銷售分析
- 巴西
- 墨西哥
- 哥倫比亞
- 阿根廷
- 其他拉丁美洲
中東和非洲
- 中東和非洲宏觀經濟展望
- 中東和非洲血管成形術支架市場：按類型分類的銷量分析
- 海灣合作理事會國家
- 其他海灣合作理事會國家
- 其他中東和非洲

第12章競爭格局

主要參與企業的策略/優勢
收入分析
市佔率分析
- 全球：周邊血管器械市場佔有率分析（2025 年）
- 美國：周邊血管器械市場佔有率分析（2025 年）
企業評估矩陣：主要企業（2025 年）
公司評估矩陣：Start-Ups/中小企業（2025 年）
品牌/產品對比
企業評估與財務指標
競爭格局

第13章：公司簡介

主要企業
- BOSTON SCIENTIFIC CORPORATION
- 貝克頓迪金森公司
- ABBOTT LABORATORIES
- CARDINAL HEALTH, INC.
- KONINKLIJKE PHILIPS NV
- TERUMO CORPORATION
- MERIT MEDICAL SYSTEMS, INC.
- B. BRAUN SE
- MEDTRONIC
- PENUMBRA, INC.
- STRYKER CORPORATION
- CORDIS
- COOK
- WL GORE & ASSOCIATES, INC.
- BIOSENSORS INTERNATIONAL GROUP, LTD.
- IVASCULAR
- BIOTRONIK
- ENDOLOGIX
- ENDOCOR GMBH & CO., KG
其他公司
- MERIL LIFE SCIENCES PVT. LTD.
- ALVIMEDICA
- CARDIONOVUM GMBH
- SMT
- MEDINOL
- ANDRAMED GMBH
- REX MEDICAL
- QMD
- BROSMED MEDICAL CO., LTD.
- ELIXIR MEDICAL

第14章調查方法

第15章附錄

簡介目錄圖表

Product Code: MD 1254

The peripheral vascular devices market is projected to reach USD 13.22 billion by 2031 from USD 10.02 billion in 2026, at a CAGR of 5.7% from 2026 to 2031.

Scope of the Report
Years Considered for the Study	2024-2031
Base Year	2025
Forecast Period	2026-2031
Units Considered	Value (USD Billion), Volume (Thousand/Million Units)
Segments	Type, End user, and Region
Regions covered	North America, Europe, APAC, LATAM, MEA

The peripheral vascular devices market is experiencing significant growth, driven by the rising prevalence of peripheral artery disease (PAD) and other vascular disorders. These conditions are largely linked to the aging population, along with rising rates of diabetes, obesity, and smoking. Innovations in minimally invasive endovascular devices, such as drug-coated balloons, next-generation stents, atherectomy systems, and embolic protection devices, are greatly improving clinical outcomes and expanding the range of patients who can be treated. Additionally, the growing preference for outpatient and ambulatory surgical center-based procedures, supported by favorable reimbursement policies in many regions, is accelerating the adoption of these devices.

Peripheral Vascular Devices Market - IMG1

Furthermore, increasing awareness of early diagnosis and treatment, improvements in healthcare infrastructure in developing countries, and ongoing investments by major manufacturers in innovation and clinical research are all contributing to market growth.

"The old/normal balloons segment is expected to grow at the highest CAGR in the angioplasty balloons market during the forecast period."

The angioplasty balloons market is experiencing increased demand for plain (standard) balloons due to their cost-effectiveness, availability of clinical expertise, and versatility across peripheral and coronary interventions. These balloons remain popular for lesion preparation, as well as for pre- and post-dilatation procedures, particularly when drug-coated options are either unnecessary or not covered by insurance. Despite the emergence of advanced balloon technologies, standard balloons continue to see strong sales in less demanding, high-volume markets, especially in developing countries, due to their ease of use, reliability, and compatibility with different stent systems.

"The embolic protection devices segment is expected to grow at the highest CAGR in the hemodynamic flow alteration devices market during the forecast period."

Embolic protection devices are expected to see increased demand in the hemodynamic flow alteration devices market. This is due to their growing use in complex endovascular and structural heart procedures, where the risk of distal embolization is notably high. The rising awareness of procedure-related complications, such as stroke and organ ischemia-especially during carotid, peripheral, and transcatheter interventions-has accelerated their clinical adoption. Additionally, improvements in device design, which enhance capture efficiency, deliverability, and vessel compatibility, have significantly supported market growth. This trend is further bolstered by the introduction of established guidelines and the expansion of minimally invasive vascular procedures.

"Based on end users, the ambulatory surgical centers segment is expected to grow at the highest CAGR in the peripheral vascular devices market during the forecast period."

The peripheral vascular devices market is experiencing significant growth, largely driven by the positive impact of ambulatory surgery centers (ASCs). These centers facilitate the shift toward minimally invasive procedures that prioritize the comfort and safety of outpatient care. ASCs offer numerous benefits, including lower procedural costs, faster patient turnover, shorter hospital stays, and improved operational efficiency, making them appealing to payers, providers, and patients alike. Innovations in peripheral vascular devices, such as miniaturized imaging systems, low-profile catheters, balloons, and atherectomy devices, have enabled even the most complex procedures to be performed in ASC settings. Additionally, favorable reimbursement policies, physician ownership models, increasing patient preference for same-day discharge, and the rising incidence of peripheral artery disease (PAD) are all contributing to the accelerated adoption of ASCs in this market.

"The Asia Pacific is estimated to register the highest CAGR during the forecast period."

The primary driver of the peripheral vascular devices market in the APAC region is the rapidly increasing incidence of peripheral artery disease (PAD) and diabetes. This trend is supported by a large aging population and a global shift towards healthier lifestyles. Countries like China, India, and Japan are leading the way in adopting these devices, driven by developing healthcare infrastructure, rising healthcare expenditures, and improved access to advanced endovascular procedures. Additionally, growing awareness of the benefits of minimally invasive interventions, an increasing number of skilled interventional specialists, and a gradual but steady expansion of reimbursement coverage in key markets are also contributing to market growth. Furthermore, low-cost manufacturing, the presence of local companies, and the strategic expansion of global medical device firms are significant drivers of this market's growth in the APAC region.

Key Players

Some of the major players in this market are Boston Scientific (US), Medtronic Plc (US), Abbott (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), B. Braun Melsungen AG (Germany), Merit Medical Systems (US), Penumbra, Inc. (US), Koninklijke Philips (Netherlands), Stryker (US), Cordis (US), W.L. Gore & Associates (US), Biotronik Stryker (US), Endologix LLC (US), and Cook Medical (US), among others.

Research Coverage

The report analyzes the peripheral vascular devices market, estimating market size and future growth potential across various segments. These segments include angioplasty stents, endovascular aneurysm repair stent grafts, inferior vena cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. Additionally, the report includes a product portfolio matrix of various peripheral vascular devices available in the market. It also provides a competitive analysis of the key players in this market, detailing their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

This report will provide market leaders and new entrants with valuable revenue estimates for the overall peripheral vascular devices market and its subsegments. It will help stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report will offer insights into the current market dynamics, highlighting key drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (rapid growth in geriatric population and resulting increase in disease prevalence and favorable reimbursement scenario for peripheral vascular procedures), restraints (availability of alternative treatment options and shortage of skilled professionals with expertise in peripheral vascular devices), opportunities (high growth potential in emerging markets and growing incidence of obesity & diabetes), and challenges (product failures and device recalls).
Product Developments/Enhancements: Comprehensive details about new product launches and anticipated trends in the global peripheral vascular devices market.
Product Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global peripheral vascular devices market.
Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users.
Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the global peripheral vascular devices market.
Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global peripheral vascular devices market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
- 1.3.1 MARKET SEGMENTATION
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN PERIPHERAL VASCULAR DEVICES MARKET
2.4 HIGH GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

3.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW
3.2 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE AND COUNTRY
3.3 PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.4 PERIPHERAL VASCULAR DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
  - 4.2.1.1 Rapid growth in geriatric population
  - 4.2.1.2 Favorable reimbursement scenario for procedures
  - 4.2.1.3 Increasing number of product approvals
  - 4.2.1.4 Rising prevalence of diabetes
  - 4.2.1.5 Growth in tobacco consumption
  - 4.2.1.6 Rising obesity rates
- 4.2.2 RESTRAINTS
  - 4.2.2.1 Increasing number of product failures and recalls
  - 4.2.2.2 Regulatory complexity and approval delays
- 4.2.3 OPPORTUNITIES
  - 4.2.3.1 High growth potential in emerging markets
  - 4.2.3.2 Increasing awareness and early diagnosis of PAD
- 4.2.4 CHALLENGES
  - 4.2.4.1 Limited availability of alternative treatments
  - 4.2.4.2 Dearth of skilled professionals with expertise in peripheral vascular devices
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 THREAT OF NEW ENTRANTS
- 5.1.2 THREAT OF SUBSTITUTES
- 5.1.3 BARGAINING POWER OF SUPPLIERS
- 5.1.4 BARGAINING POWER OF BUYERS
- 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMICS INDICATORS
- 5.2.1 INTRODUCTION
- 5.2.2 GDP TRENDS AND FORECAST
- 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
- 5.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
5.3 SUPPLY CHAIN ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 PRICING ANALYSIS
- 5.6.1 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYERS, 2023-2025
- 5.6.2 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023-2025
5.7 TRADE ANALYSIS
- 5.7.1 IMPORT DATA FOR HS CODE 901839
- 5.7.2 EXPORT DATA FOR HS CODE 901839
5.8 KEY CONFERENCES AND EVENTS, 2026-2027
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10 INVESTMENT AND FUNDING SCENARIO
5.11 CASE STUDY ANALYSIS
- 5.11.1 MEDTRONIC
- 5.11.2 TERUMO
- 5.11.3 BOSTON SCIENTIFIC CORPORATION
5.12 IMPACT OF 2025 US TARIFFS - PERIPHERAL VASCULAR DEVICES MARKET
- 5.12.1 INTRODUCTION
- 5.12.2 KEY TARIFF RATES
- 5.12.3 PRICE IMPACT ANALYSIS
- 5.12.4 IMPACT ON COUNTRIES/REGIONS
  - 5.12.4.1 US
  - 5.12.4.2 Europe
  - 5.12.4.3 Asia Pacific
- 5.12.5 IMPACT ON END-USE INDUSTRIES
  - 5.12.5.1 Hospitals
    - 5.12.5.1.1 Large chain hospitals
    - 5.12.5.1.2 Standalone hospital facilities
  - 5.12.5.2 Ambulatory care settings
  - 5.12.5.3 Cardiac care centers
  - 5.12.5.4 Other end users

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY EMERGING TECHNOLOGIES
  - 6.1.1.1 Drug-eluting stents
  - 6.1.1.2 Atherectomy devices
- 6.1.2 COMPLEMENTARY TECHNOLOGIES
  - 6.1.2.1 Intravascular ultrasound
  - 6.1.2.2 Optical coherence tomography
- 6.1.3 ADJACENT TECHNOLOGIES
  - 6.1.3.1 Remote patient monitoring
  - 6.1.3.2 3D printing and patient-specific modeling
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
- 6.3.1 INSIGHTS ON PATENT PUBLICATION TRENDS, TOP APPLICANTS AND JURISDICTION FOR PERIPHERAL VASCULAR DEVICES MARKET, JANUARY 2015-DECEMBER 2025
- 6.3.2 LIST OF MAJOR PATENTS, 2023-2026
6.4 FUTURE APPLICATIONS
- 6.4.1 INTRAVASCULAR LITHOTRIPSY FOR CALCIFIED PAD LESIONS
- 6.4.2 ADVANCED IMAGE-GUIDED INTERVENTIONS
- 6.4.3 SMART SENSOR-INTEGRATED VASCULAR IMPLANTS
- 6.4.4 INTEGRATED MULTI-FUNCTION ENDOVASCULAR DEVICES
6.5 IMPACT OF AI ON PERIPHERAL VASCULAR DEVICES MARKET

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

7.1 REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 INDUSTRY STANDARDS
  - 7.1.2.1 Medical Device Quality Management Standard (ISO 13485)
  - 7.1.2.2 Biological Evaluation and Biocompatibility of Medical Devices (ISO 10993)
  - 7.1.2.3 Vascular Stent Performance Standard (ISO 25539-2)
  - 7.1.2.4 Intravascular Access Device Standard (ISO 11070)
7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 SUSTAINABLE PACKAGING AND DIGITAL INSTRUCTIONS (BOSTON SCIENTIFIC CASE STUDY)
- 7.2.2 SUSTAINABLE PRODUCT LIFECYCLE MANAGEMENT (ABBOTT CASE STUDY)
- 7.2.3 PACKAGING WASTE REDUCTION INITIATIVE BY MEDTRONIC
7.3 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

8.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS
8.5 MARKET PROFITABILITY
- 8.5.1 SHIFT TOWARD HIGH-VALUE, DRUG-ELUTING, AND SPECIALTY DEVICES
- 8.5.2 PROCEDURE VOLUME GROWTH DRIVEN BY AGING POPULATION AND PAD PREVALENCE
- 8.5.3 COST OPTIMIZATION THROUGH SUPPLY CHAIN EFFICIENCY AND PORTFOLIO BREADTH

9 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE

9.1 INTRODUCTION
9.2 ANGIOPLASTY STENTS MARKET, BY TYPE
- 9.2.1 VOLUME ANALYSIS: ANGIOPLASTY STENTS MARKET, BY TYPE
- 9.2.2 DRUG-ELUTING STENTS
  - 9.2.2.1 Drug-eluting stents to witness higher adoption due to technological advancements leading to lower restenosis rate
- 9.2.3 BARE-METAL STENTS
  - 9.2.3.1 Bare-metal stents, by delivery platform
    - 9.2.3.1.1 Balloon-expandable stents
      - 9.2.3.1.1.1 Better radial strength and ease of deployment to drive usage
    - 9.2.3.1.2 Self-expandable stents
      - 9.2.3.1.2.1 Flexibility, tolerance, and support for vessel movement and compression to propel market
9.3 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE
- 9.3.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS
  - 9.3.1.1 Rising prevalence of AAA and need for less invasive treatment to drive market
- 9.3.2 THORACIC AORTIC ANEURYSM STENT GRAFTS
  - 9.3.2.1 Increasing incidence of thoracic aortic aneurysms to propel adoption
9.4 CATHETERS MARKET, BY TYPE
- 9.4.1 ANGIOGRAPHY CATHETERS
  - 9.4.1.1 Angiography catheters to dominate catheters market
- 9.4.2 GUIDING CATHETERS
  - 9.4.2.1 Growing number of target procedures to drive demand for guiding catheters
- 9.4.3 IVUS/OCT CATHETERS
  - 9.4.3.1 IVUS/OCT catheters segment to register highest growth
9.5 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE
- 9.5.1 RETRIEVABLE FILTERS
  - 9.5.1.1 Retrievable filters segment to register higher growth due to increase in use as temporary measure to block pulmonary embolism
- 9.5.2 PERMANENT FILTERS
  - 9.5.2.1 Advances in other technologies and risks associated with permanent filters to hamper sales
9.6 ANGIOPLASTY BALLOONS MARKET, BY TYPE
- 9.6.1 OLD/NORMAL BALLOONS
  - 9.6.1.1 Old/normal balloons to dominate angioplasty balloons market as they remain effective and widely used
- 9.6.2 DRUG-ELUTING BALLOONS
  - 9.6.2.1 Drug-eluting balloons to witness highest growth with increasing demand for angioplasty procedures and rising regulatory approvals for DEBs
- 9.6.3 CUTTING & SCORING BALLOONS
  - 9.6.3.1 Preference for medication as primary treatment for atherosclerosis to restrain adoption
9.7 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE
- 9.7.1 ATHERECTOMY DEVICES
  - 9.7.1.1 Increase in incidence of atherosclerosis to drive market
- 9.7.2 THROMBECTOMY DEVICES
  - 9.7.2.1 Growing DVT incidence to drive adoption of thrombectomy devices
9.8 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE
- 9.8.1 EMBOLIC PROTECTION DEVICES
  - 9.8.1.1 Investments in technological advancements and growing regulatory approvals to drive market
- 9.8.2 CHRONIC TOTAL OCCLUSION DEVICES
  - 9.8.2.1 Rise in support for device development especially in addressing longstanding plaque buildup to drive market
9.9 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
- 9.9.1 GUIDEWIRES
  - 9.9.1.1 Higher success rate during stenting and endovascular aneurysm repair contribute to largest market share
- 9.9.2 VASCULAR CLOSURE DEVICES
  - 9.9.2.1 Technological advancements and minimized duration of hospital stay to support demand
- 9.9.3 INTRODUCER SHEATHS
  - 9.9.3.1 Potential for reducing arterial damage during interventional procedures to drive adoption
- 9.9.4 BALLOON INFLATION DEVICES
  - 9.9.4.1 Integrated technologies and rising number of target procedures to propel adoption

10 PERIPHERAL VASCULAR DEVICES MARKET, BY END USER

10.1 INTRODUCTION
10.2 HOSPITALS
- 10.2.1 ADVANCED INFRASTRUCTURE AND SPECIALIZED EQUIPMENT TO DRIVE SEGMENT GROWTH
- 10.2.2 LARGE CHAIN HOSPITALS
  - 10.2.2.1 Strong infrastructure and integrated networks driving dominance in complex peripheral vascular procedures
- 10.2.3 STANDALONE HOSPITAL FACILITIES
  - 10.2.3.1 Expanding accessibility and cost-effective care to support peripheral vascular procedure volumes
10.3 AMBULATORY SURGICAL CENTERS
- 10.3.1 FASTER PROCEDURE TIME AND LOWER INFECTION RATES TO DRIVE SEGMENT GROWTH
10.4 OTHER END USERS

11 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 NORTH AMERICA ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE
- 11.2.3 US
  - 11.2.3.1 Favorable reimbursement scenario to contribute to market growth
- 11.2.4 CANADA
  - 11.2.4.1 Increasing cases of chronic conditions to fuel market
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 EUROPE ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE
- 11.3.3 GERMANY
  - 11.3.3.1 Statutory health insurance policy to support market growth
- 11.3.4 FRANCE
  - 11.3.4.1 Growing geriatric population to drive market
- 11.3.5 UK
  - 11.3.5.1 Increasing volume of coronary angioplasty procedures to sustain market growth
- 11.3.6 SPAIN
  - 11.3.6.1 Growing cases of diabetes and obesity to boost market
- 11.3.7 ITALY
  - 11.3.7.1 Increasing prevalence of atherosclerotic cardiovascular disease to spur market growth
- 11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 ASIA PACIFIC ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE
- 11.4.3 JAPAN
  - 11.4.3.1 Large geriatric population to ensure sustained demand
- 11.4.4 CHINA
  - 11.4.4.1 Growing incidence of lifestyle diseases to fuel market
- 11.4.5 INDIA
  - 11.4.5.1 Rising prevalence of target diseases and growing healthcare expenditure to propel market
- 11.4.6 AUSTRALIA
  - 11.4.6.1 High prevalence of cardiovascular and peripheral artery diseases to drive market
- 11.4.7 SOUTH KOREA
  - 11.4.7.1 Rising rates of chronic diseases to boost market
- 11.4.8 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 LATIN AMERICA ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE
- 11.5.3 BRAZIL
  - 11.5.3.1 Rising healthcare expenditure to aid market growth
- 11.5.4 MEXICO
  - 11.5.4.1 Increasing prevalence of cardiovascular diseases to spur market growth
- 11.5.5 COLOMBIA
  - 11.5.5.1 Growing incidence of peripheral artery diseases to expedite market growth
- 11.5.6 ARGENTINA
  - 11.5.6.1 Increasing prevalence of peripheral artery diseases to support market growth
- 11.5.7 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
- 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 11.6.2 MIDDLE EAST & AFRICA ANGIOPLASTY STENTS MARKET: VOLUME ANALYSIS, BY TYPE
- 11.6.3 GCC COUNTRIES
  - 11.6.3.1 Kingdom of Saudi Arabia (KSA)
    - 11.6.3.1.1 Rising diabetes prevalence and strong government healthcare investments to drive market
  - 11.6.3.2 United Arab Emirates (UAE)
    - 11.6.3.2.1 Advanced healthcare infrastructure and growing medical tourism to accelerate peripheral vascular devices adoption
- 11.6.4 REST OF GCC COUNTRIES
- 11.6.5 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
- 12.4.1 GLOBAL: PERIPHERAL VASCULAR DEVICES MARKET SHARE ANALYSIS, 2025
- 12.4.2 US: PERIPHERAL VASCULAR DEVICES MARKET SHARE ANALYSIS, 2025
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
  - 12.5.5.1 Company footprint
  - 12.5.5.2 Regional footprint
  - 12.5.5.3 Product type footprint
  - 12.5.5.4 End user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 DYNAMIC COMPANIES
- 12.6.3 RESPONSIVE COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
12.7 BRAND/PRODUCT COMPARISON
12.8 COMPANY VALUATION AND FINANCIAL METRICS
- 12.8.1 FINANCIAL METRICS
- 12.8.2 COMPANY VALUATION
12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES AND APPROVALS
- 12.9.2 DEALS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 BOSTON SCIENTIFIC CORPORATION
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Product approvals
    - 13.1.1.3.2 Deals
    - 13.1.1.3.3 Other developments
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Right to win
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses and competitive threats
- 13.1.2 BECTON, DICKINSON AND COMPANY
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Product launches and approvals
    - 13.1.2.3.2 Deals
    - 13.1.2.3.3 Expansions
    - 13.1.2.3.4 Other developments
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Right to win
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses and competitive threats
- 13.1.3 ABBOTT LABORATORIES
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products offered
  - 13.1.3.3 Recent developments
    - 13.1.3.3.1 Product launches
    - 13.1.3.3.2 Deals
    - 13.1.3.3.3 Expansions
  - 13.1.3.4 MnM view
    - 13.1.3.4.1 Right to win
    - 13.1.3.4.2 Strategic choices made
    - 13.1.3.4.3 Weaknesses and competitive threats
- 13.1.4 CARDINAL HEALTH, INC.
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Product launches
    - 13.1.4.3.2 Deals
    - 13.1.4.3.3 Expansions
  - 13.1.4.4 MnM view
    - 13.1.4.4.1 Right to win
    - 13.1.4.4.2 Strategic choices
    - 13.1.4.4.3 Weaknesses and competitive threats
- 13.1.5 KONINKLIJKE PHILIPS N.V.
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Product approvals
    - 13.1.5.3.2 Deals
    - 13.1.5.3.3 Expansions
  - 13.1.5.4 MnM view
    - 13.1.5.4.1 Right to win
    - 13.1.5.4.2 Strategic choices
    - 13.1.5.4.3 Weaknesses and competitive threats
- 13.1.6 TERUMO CORPORATION
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Product launches
    - 13.1.6.3.2 Deals
    - 13.1.6.3.3 Expansions
- 13.1.7 MERIT MEDICAL SYSTEMS, INC.
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Product launches
    - 13.1.7.3.2 Deals
- 13.1.8 B. BRAUN SE
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Product approvals
- 13.1.9 MEDTRONIC
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products offered
  - 13.1.9.3 Recent developments
    - 13.1.9.3.1 Product launches and approvals
    - 13.1.9.3.2 Deals
- 13.1.10 PENUMBRA, INC.
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products offered
  - 13.1.10.3 Recent developments
    - 13.1.10.3.1 Product launches and approvals
- 13.1.11 STRYKER CORPORATION
  - 13.1.11.1 Business overview
  - 13.1.11.2 Products offered
  - 13.1.11.3 Recent developments
    - 13.1.11.3.1 Deals
- 13.1.12 CORDIS
  - 13.1.12.1 Business overview
  - 13.1.12.2 Products offered
  - 13.1.12.3 Recent developments
    - 13.1.12.3.1 Product approvals
    - 13.1.12.3.2 Deals
- 13.1.13 COOK
  - 13.1.13.1 Business overview
  - 13.1.13.2 Products offered
  - 13.1.13.3 Recent developments
    - 13.1.13.3.1 Deals
- 13.1.14 W. L. GORE & ASSOCIATES, INC.
  - 13.1.14.1 Business overview
  - 13.1.14.2 Products offered
  - 13.1.14.3 Recent developments
    - 13.1.14.3.1 Product approvals
- 13.1.15 BIOSENSORS INTERNATIONAL GROUP, LTD.
  - 13.1.15.1 Business overview
  - 13.1.15.2 Products offered
- 13.1.16 IVASCULAR
  - 13.1.16.1 Business overview
  - 13.1.16.2 Products offered
- 13.1.17 BIOTRONIK
  - 13.1.17.1 Business overview
  - 13.1.17.2 Products offered
  - 13.1.17.3 Recent developments
    - 13.1.17.3.1 Product launches
- 13.1.18 ENDOLOGIX
  - 13.1.18.1 Business overview
  - 13.1.18.2 Products offered
- 13.1.19 ENDOCOR GMBH & CO., KG
  - 13.1.19.1 Business overview
  - 13.1.19.2 Products offered
13.2 OTHER PLAYERS
- 13.2.1 MERIL LIFE SCIENCES PVT. LTD.
- 13.2.2 ALVIMEDICA
- 13.2.3 CARDIONOVUM GMBH
- 13.2.4 SMT
- 13.2.5 MEDINOL
- 13.2.6 ANDRAMED GMBH
- 13.2.7 REX MEDICAL
- 13.2.8 QMD
- 13.2.9 BROSMED MEDICAL CO., LTD.
- 13.2.10 ELIXIR MEDICAL

14 RESEARCH METHODOLOGY

14.1 RESEARCH DATA
- 14.1.1 SECONDARY DATA
  - 14.1.1.1 Key data from secondary sources
- 14.1.2 PRIMARY DATA
  - 14.1.2.1 Key data from primary sources
  - 14.1.2.2 Key industry insights
  - 14.1.2.3 Key industry insights
14.2 MARKET SIZE ESTIMATION
14.3 GROWTH FORECAST
- 14.3.1 KEY INDUSTRY INSIGHTS
14.4 MARKET BREAKDOWN AND DATA TRIANGULATION
14.5 RESEARCH ASSUMPTIONS
14.6 RISK ASSESSMENT
14.7 RESEARCH LIMITATIONS

15 APPENDIX

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
- 15.3.1 PRODUCT ANALYSIS
- 15.3.2 US: END-USER ANALYSIS
- 15.3.3 GEOGRAPHIC ANALYSIS
- 15.3.4 COMPANY INFORMATION
- 15.3.5 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
- 15.3.6 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE
- 15.3.7 MARKET SHARE ANALYSIS, BY PRODUCT TYPE (TOP FIVE PLAYERS)
- 15.3.8 ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

簡介目錄圖表

List of Tables

TABLE 1 INCLUSIONS & EXCLUSIONS
TABLE 2 STANDARD CURRENCY CONVERSION RATES
TABLE 3 GLOBAL GERIATRIC POPULATION TRENDS (2015 VS. 2030): REGIONAL BREAKDOWN
TABLE 4 US: REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES, 2026 (USD)
TABLE 5 PRODUCT APPROVALS IN PERIPHERAL VASCULAR DEVICES MARKET, 2023-2024
TABLE 6 DIABETES POPULATION, BY REGION, 2024 VS. 2050
TABLE 7 TOP 10 COUNTRIES WITH HIGHEST SMOKING RATE, 2025
TABLE 8 OBESITY RATE IN DEVELOPING COUNTRIES, 2026
TABLE 9 PRODUCT FAILURES AND RECALLS
TABLE 10 UNMET NEEDS AND WHITE SPACES
TABLE 11 INTERCONNECTED MARKETS
TABLE 12 CROSS-SECTOR OPPORTUNITIES
TABLE 13 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
TABLE 14 IMPACT OF PORTER'S FIVE FORCES ON PERIPHERAL VASCULAR DEVICES MARKET
TABLE 15 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2023-2025 (USD)
TABLE 16 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2023-2025 (USD)
TABLE 17 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
TABLE 18 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
TABLE 19 PERIPHERAL VASCULAR DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
TABLE 20 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 21 PERIPHERAL VASCULAR DEVICES MARKET: TECHNOLOGY/PRODUCT ROADMAP (2026-2035)
TABLE 22 PERIPHERAL VASCULAR DEVICES MARKET: LIST OF MAJOR PATENTS, JANUARY 2023-FEBRUARY 2026
TABLE 23 AI INTEGRATION: PERIPHERAL VASCULAR DEVICES MARKET
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIPHERAL VASCULAR DEVICES
TABLE 30 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 31 PERIPHERAL VASCULAR DEVICES MARKET: UNMET NEEDS IN KEY END-USE SETTINGS
TABLE 32 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 33 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
TABLE 34 ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 35 ANGIOPLASTY STENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 36 DRUG-ELUTING STENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 37 BARE-METAL STENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 38 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM, 2024-2031 (USD MILLION)
TABLE 39 BALLOON-EXPANDABLE STENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 40 SELF-EXPANDABLE STENTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 41 EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 42 EVAR STENT GRAFTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 43 AAA STENT GRAFTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 44 TAA STENT GRAFTS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 45 CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 46 CATHETERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 47 ANGIOGRAPHY CATHETERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 48 GUIDING CATHETERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 49 IVUS/OCT CATHETERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 50 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 51 INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 52 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 53 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 54 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 55 ANGIOPLASTY BALLOONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 56 OLD/NORMAL BALLOONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 57 DRUG-ELUTING BALLOONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 58 CUTTING & SCORING BALLOONS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 59 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 60 PLAQUE MODIFICATION DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 61 ATHERECTOMY DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 62 THROMBECTOMY DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 63 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 64 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 65 EMBOLIC PROTECTION DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 66 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 67 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 68 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 69 GUIDEWIRES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 70 VASCULAR CLOSURE DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 71 INTRODUCER SHEATHS MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 72 BALLOON INFLATION DEVICES MARKET, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 73 PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 74 PERIPHERAL VASCULAR DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
TABLE 75 PERIPHERAL VASCULAR DEVICES MARKET FOR HOSPITALS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 76 PERIPHERAL VASCULAR DEVICES MARKET FOR LARGE CHAIN HOSPITALS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 77 PERIPHERAL VASCULAR DEVICES MARKET FOR STANDALONE HOSPITAL FACILITIES SEGMENT, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 78 PERIPHERAL VASCULAR DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 79 PERIPHERAL VASCULAR DEVICES MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2024-2031 (USD MILLION)
TABLE 80 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 81 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 82 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 83 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 84 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
TABLE 85 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 86 NORTH AMERICA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 87 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 88 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 89 NORTH AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 90 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 91 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 92 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 93 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 94 NORTH AMERICA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 95 US: MACROECONOMIC INDICATORS
TABLE 96 US: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 97 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 98 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 99 US: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 100 US: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 101 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 102 US: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 103 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 105 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 106 US: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 107 US: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 108 CANADA: MACROECONOMIC INDICATORS
TABLE 109 CANADA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 110 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 111 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 112 CANADA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 113 CANADA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 114 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 115 CANADA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 116 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 117 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 118 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 119 CANADA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 120 CANADA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 122 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 123 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 124 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
TABLE 125 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 126 EUROPE: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 127 EUROPE: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 128 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 129 EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 130 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 131 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 132 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 133 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 134 EUROPE: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 135 GERMANY: MACROECONOMIC INDICATORS
TABLE 136 GERMANY: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 137 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 138 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 139 GERMANY: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 140 GERMANY: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 141 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 142 GERMANY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 143 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 144 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 145 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 146 GERMANY: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 147 GERMANY: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 148 FRANCE: MACROECONOMIC INDICATORS
TABLE 149 FRANCE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 150 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 151 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 152 FRANCE: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 153 FRANCE: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 154 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 FRANCE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 156 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 157 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 158 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 159 FRANCE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 160 FRANCE: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 161 UK: MACROECONOMIC INDICATORS
TABLE 162 UK: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 163 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 165 UK: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 166 UK: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 167 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 168 UK: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 169 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 170 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 171 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 172 UK: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 173 UK: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 174 SPAIN: MACROECONOMIC INDICATORS
TABLE 175 SPAIN: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 176 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 177 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 178 SPAIN: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 179 SPAIN: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 180 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 SPAIN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 182 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 183 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 184 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 185 SPAIN: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 186 SPAIN: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 187 ITALY: MACROECONOMIC INDICATORS
TABLE 188 ITALY: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 189 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 190 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 191 ITALY: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 192 ITALY: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 193 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 194 ITALY: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 195 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 196 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 198 ITALY: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 199 ITALY: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 200 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030
TABLE 201 REST OF EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 202 REST OF EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 203 REST OF EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 204 REST OF EUROPE: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 REST OF EUROPE: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 206 REST OF EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 207 REST OF EUROPE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 208 REST OF EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 209 REST OF EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 210 REST OF EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 211 REST OF EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 212 REST OF EUROPE: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 213 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 214 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 215 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 216 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
TABLE 217 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 218 ASIA PACIFIC: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 219 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 220 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 221 ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 222 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 223 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 224 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 225 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 226 ASIA PACIFIC: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 227 JAPAN: MACROECONOMIC INDICATORS
TABLE 228 JAPAN: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 229 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 231 JAPAN: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 232 JAPAN: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 233 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 234 JAPAN: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 235 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 236 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 237 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 238 JAPAN: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 239 JAPAN: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 240 CHINA: MACROECONOMIC INDICATORS
TABLE 241 CHINA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 242 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 243 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 244 CHINA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 245 CHINA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 246 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 247 CHINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 248 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 249 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 250 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 251 CHINA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 252 CHINA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 253 INDIA: MACROECONOMIC INDICATORS
TABLE 254 INDIA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 255 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 256 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 257 INDIA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 258 INDIA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 259 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 260 INDIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 261 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 262 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 264 INDIA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 265 INDIA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 266 AUSTRALIA: MACROECONOMIC INDICATORS
TABLE 267 AUSTRALIA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 268 AUSTRALIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 269 AUSTRALIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 270 AUSTRALIA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 271 AUSTRALIA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 272 AUSTRALIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 273 AUSTRALIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 274 AUSTRALIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 275 AUSTRALIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 276 AUSTRALIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 277 AUSTRALIA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 278 AUSTRALIA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 279 SOUTH KOREA: MACROECONOMIC INDICATORS
TABLE 280 SOUTH KOREA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 281 SOUTH KOREA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 282 SOUTH KOREA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 283 SOUTH KOREA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 284 SOUTH KOREA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 285 SOUTH KOREA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 286 SOUTH KOREA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 287 SOUTH KOREA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 288 SOUTH KOREA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 289 SOUTH KOREA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 290 SOUTH KOREA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 291 SOUTH KOREA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 292 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 293 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 294 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 295 REST OF ASIA PACIFIC: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 296 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 297 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 298 REST OF ASIA PACIFIC: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 299 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 300 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 301 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 302 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 303 REST OF ASIA PACIFIC: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 304 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 305 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 306 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 307 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
TABLE 308 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 309 LATIN AMERICA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 310 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 311 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 312 LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 313 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 314 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 315 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 316 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 317 LATIN AMERICA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 318 BRAZIL: MACROECONOMIC INDICATORS
TABLE 319 BRAZIL: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 320 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 321 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 322 BRAZIL: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 323 BRAZIL: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 324 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 325 BRAZIL: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 326 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 327 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 328 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 329 BRAZIL: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 330 BRAZIL: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 331 MEXICO: MACROECONOMIC INDICATORS
TABLE 332 MEXICO: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 333 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 334 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 335 MEXICO: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 336 MEXICO: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 337 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 338 MEXICO: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 339 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 340 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 341 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 342 MEXICO: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 343 MEXICO: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 344 COLOMBIA: MACROECONOMIC INDICATORS
TABLE 345 COLOMBIA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 346 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 347 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 348 COLOMBIA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 349 COLOMBIA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 350 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 351 COLOMBIA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 352 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 353 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 354 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 355 COLOMBIA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 356 COLOMBIA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 357 ARGENTINA: MACROECONOMIC INDICATORS
TABLE 358 ARGENTINA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 359 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 360 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 361 ARGENTINA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 362 ARGENTINA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 363 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 364 ARGENTINA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 365 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 366 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 367 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 368 ARGENTINA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 369 ARGENTINA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 370 REST OF LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 371 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 372 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 373 REST OF LATIN AMERICA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 374 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 375 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 376 REST OF LATIN AMERICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 377 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 378 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 379 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 380 REST OF LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 381 REST OF LATIN AMERICA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 382 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 383 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 384 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 385 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
TABLE 386 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 387 MIDDLE EAST & AFRICA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 388 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 389 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 390 MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 391 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 392 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 393 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 394 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 395 MIDDLE EAST & AFRICA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 396 GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 397 GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 398 GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 399 GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 400 GCC COUNTRIES: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 401 GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 402 GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 403 GCC COUNTRIES: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 404 GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 405 GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 406 GCC COUNTRIES: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 407 GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 408 GCC COUNTRIES: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 409 KSA: MACROECONOMIC INDICATORS
TABLE 410 KSA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 411 KSA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 412 KSA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 413 KSA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 414 KSA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 415 KSA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 416 KSA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 417 KSA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 418 KSA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 419 KSA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 420 KSA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 421 KSA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 422 UAE: MACROECONOMIC INDICATORS
TABLE 423 UAE: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 424 UAE: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 425 UAE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 426 UAE: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 427 UAE: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 428 UAE: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 429 UAE: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 430 UAE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 431 UAE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 432 UAE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 433 UAE: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 434 UAE: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 435 REST OF GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 436 REST OF GCC COUNTRIES: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 437 REST OF GCC COUNTRIES: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 438 REST OF GCC COUNTRIES: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 439 REST OF GCC COUNTRIES: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 440 REST OF GCC COUNTRIES: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 441 REST OF GCC COUNTRIES: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 442 REST OF GCC COUNTRIES: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 443 REST OF GCC COUNTRIES: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 444 REST OF GCC COUNTRIES: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 445 REST OF GCC COUNTRIES: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 446 REST OF GCC COUNTRIES: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 447 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT TYPE, 2024-2031 (USD MILLION)
TABLE 448 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 449 REST OF MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 450 REST OF MIDDLE EAST & AFRICA: BARE-METAL STENTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 451 REST OF MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 452 REST OF MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 453 REST OF MIDDLE EAST & AFRICA: INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 454 REST OF MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 455 REST OF MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 456 REST OF MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 457 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 458 REST OF MIDDLE EAST & AFRICA: HOSPITALS MARKET, BY TYPE, 2024-2031 (USD MILLION)
TABLE 459 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET
TABLE 460 PERIPHERAL VASCULAR DEVICES MARKET: DEGREE OF COMPETITION
TABLE 461 PERIPHERAL VASCULAR DEVICES MARKET: REGIONAL FOOTPRINT, 2025
TABLE 462 PERIPHERAL VASCULAR DEVICES MARKET: PRODUCT TYPE FOOTPRINT, 2025
TABLE 463 PERIPHERAL VASCULAR DEVICES MARKET: END USER FOOTPRINT, 2025
TABLE 464 PERIPHERAL VASCULAR DEVICES MARKET: KEY STARTUPS/SMES, 2025
TABLE 465 PERIPHERAL VASCULAR DEVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
TABLE 466 PERIPHERAL VASCULAR DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MARCH 2026
TABLE 467 PERIPHERAL VASCULAR DEVICES MARKET: DEALS, JANUARY 2023-MARCH 2026
TABLE 468 PERIPHERAL VASCULAR DEVICES MARKET: EXPANSIONS, JANUARY 2023-MARCH 2026
TABLE 469 PERIPHERAL VASCULAR DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2023-MARCH 2026
TABLE 470 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
TABLE 471 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
TABLE 472 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS
TABLE 473 BOSTON SCIENTIFIC CORPORATION: DEALS
TABLE 474 BOSTON SCIENTIFIC CORPORATION: OTHER DEVELOPMENTS
TABLE 475 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 476 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
TABLE 477 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS
TABLE 478 BECTON, DICKINSON AND COMPANY: DEALS
TABLE 479 BECTON, DICKINSON AND COMPANY: EXPANSIONS
TABLE 480 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS
TABLE 481 ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 482 ABBOTT LABORATORIES: PRODUCTS OFFERED
TABLE 483 ABBOTT LABORATORIES: PRODUCT LAUNCHES
TABLE 484 ABBOTT LABORATORIES: DEALS
TABLE 485 ABBOTT LABORATORIES: EXPANSIONS
TABLE 486 CARDINAL HEALTH, INC.: COMPANY OVERVIEW
TABLE 487 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
TABLE 488 CARDINAL HEALTH, INC.: PRODUCT LAUNCHES
TABLE 489 CARDINAL HEALTH, INC.: DEALS
TABLE 490 CARDINAL HEALTH, INC.: EXPANSIONS
TABLE 491 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 492 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 493 KONINKLIJKE PHILIPS N.V.: PRODUCT APPROVALS
TABLE 494 KONINKLIJKE PHILIPS N.V.: DEALS
TABLE 495 KONINKLIJKE PHILIPS N.V.: EXPANSIONS
TABLE 496 TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 497 TERUMO CORPORATION: PRODUCTS OFFERED
TABLE 498 TERUMO CORPORATION: PRODUCT LAUNCHES
TABLE 499 TERUMO CORPORATION: DEALS
TABLE 500 TERUMO CORPORATION: EXPANSIONS
TABLE 501 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 502 MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED
TABLE 503 MERIT MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES
TABLE 504 MERIT MEDICAL SYSTEMS, INC.: DEALS
TABLE 505 B. BRAUN SE: COMPANY OVERVIEW
TABLE 506 B. BRAUN SE: PRODUCTS OFFERED
TABLE 507 B. BRAUN SE: PRODUCT APPROVALS
TABLE 508 MEDTRONIC: COMPANY OVERVIEW
TABLE 509 MEDTRONIC: PRODUCTS OFFERED
TABLE 510 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS
TABLE 511 MEDTRONIC: DEALS
TABLE 512 PENUMBRA, INC.: COMPANY OVERVIEW
TABLE 513 PENUMBRA, INC.: PRODUCTS OFFERED
TABLE 514 PENUMBRA, INC.: PRODUCT LAUNCHES AND APPROVALS
TABLE 515 STRYKER CORPORATION: COMPANY OVERVIEW
TABLE 516 STRYKER CORPORATION: PRODUCTS OFFERED
TABLE 517 STRYKER CORPORATION: DEALS
TABLE 518 CORDIS: COMPANY OVERVIEW
TABLE 519 CORDIS: PRODUCTS OFFERED
TABLE 520 CORDIS: PRODUCT APPROVALS
TABLE 521 CORDIS: DEALS
TABLE 522 COOK: COMPANY OVERVIEW
TABLE 523 COOK: PRODUCTS OFFERED
TABLE 524 COOK: DEALS
TABLE 525 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
TABLE 526 W. L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED
TABLE 527 W. L. GORE & ASSOCIATES, INC: PRODUCT APPROVALS
TABLE 528 BIOSENSORS INTERNATIONAL GROUP, LTD.: COMPANY OVERVIEW
TABLE 529 BIOSENSORS INTERNATIONAL GROUP, LTD.: PRODUCTS OFFERED
TABLE 530 IVASCULAR: COMPANY OVERVIEW
TABLE 531 IVASCULAR: PRODUCTS OFFERED
TABLE 532 BIOTRONIK: COMPANY OVERVIEW
TABLE 533 BIOTRONIK: PRODUCTS OFFERED
TABLE 534 BIOTRONIK: PRODUCT LAUNCHES
TABLE 535 ENDOLOGIX: COMPANY OVERVIEW
TABLE 536 ENDOLOGIX: PRODUCTS OFFERED
TABLE 537 ENDOCOR GMBH & CO., KG: COMPANY OVERVIEW
TABLE 538 ENDOCOR GMBH & CO., KG: PRODUCTS OFFERED
TABLE 539 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
TABLE 540 ALVIMEDICA: COMPANY OVERVIEW
TABLE 541 CARDIONOVUM GMBH: COMPANY OVERVIEW
TABLE 542 SMT: COMPANY OVERVIEW
TABLE 543 MEDINOL: COMPANY OVERVIEW
TABLE 544 ANDRAMED GMBH: COMPANY OVERVIEW
TABLE 545 REX MEDICAL: COMPANY OVERVIEW
TABLE 546 QMD: COMPANY OVERVIEW
TABLE 547 BROSMED MEDICAL CO., LTD.: COMPANY OVERVIEW
TABLE 548 ELIXIR MEDICAL: COMPANY OVERVIEW

List of Figures

FIGURE 1 MARKETS COVERED
FIGURE 2 STUDY YEARS
FIGURE 3 MARKET SCENARIO
FIGURE 4 GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, 2024-2031
FIGURE 5 PERIPHERAL VASCULAR DEVICES MARKET: MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, 2022-2025
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PERIPHERAL VASCULAR DEVICES MARKET
FIGURE 7 PERIPHERAL VASCULAR DEVICES MARKET: HIGH-GROWTH SEGMENTS, 2026-2031
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PERIPHERAL VASCULAR DEVICES MARKET DURING FORECAST PERIOD
FIGURE 9 RISING PREVALENCE OF PERIPHERAL ARTERY DISEASE (PAD) TO DRIVE MARKET
FIGURE 10 ANGIOPLASTY STENT PRODUCTS AND CHINA LED RESPECTIVE MARKET SEGMENTS IN 2025
FIGURE 11 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 12 INDIA TO REGISTER HIGHER GROWTH RATES THAN EMERGING ECONOMIES DURING FORECAST PERIOD
FIGURE 13 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 PERIPHERAL VASCULAR DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 15 PERIPHERAL VASCULAR DEVICES MARKET: SUPPLY CHAIN
FIGURE 16 PERIPHERAL VASCULAR DEVICES MARKET: VALUE CHAIN ANALYSIS (2025)
FIGURE 17 PERIPHERAL VASCULAR DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 18 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
FIGURE 19 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2021-2025 (USD MILLION)
FIGURE 20 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 21 INVESTMENT/VENTURE CAPITAL SCENARIO IN PERIPHERAL VASCULAR DEVICES MARKET, 2021-2025
FIGURE 22 PATENTS APPLIED AND GRANTED, 2015-2025
FIGURE 23 TOP APPLICANT COUNTRIES/REGIONS FOR PERIPHERAL VASCULAR PATENTS, 2015-2025
FIGURE 24 PERIPHERAL VASCULAR DEVICES MARKET: DECISION-MAKING FACTORS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PERIPHERAL VASCULAR DEVICES
FIGURE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 27 ADOPTION BARRIERS AND INTERNAL CHALLENGES
FIGURE 28 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET SNAPSHOT
FIGURE 30 REVENUE ANALYSIS FOR KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET, 2023-2025 (USD MILLION)
FIGURE 31 GLOBAL SHARE ANALYSIS OF KEY PLAYERS IN PERIPHERAL VASCULAR DEVICES MARKET, 2025
FIGURE 32 US: PERIPHERAL VASCULAR DEVICES MARKET SHARE ANALYSIS, 2025
FIGURE 33 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 34 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY FOOTPRINT, 2025
FIGURE 35 PERIPHERAL VASCULAR DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 36 PERIPHERAL VASCULAR DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 37 EV/EBITDA OF KEY VENDORS, 2024
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2024
FIGURE 39 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT, 2025
FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT, 2025
FIGURE 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT, 2025
FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT, 2025
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT, 2025
FIGURE 44 TERUMO CORPORATION: COMPANY SNAPSHOT, 2025
FIGURE 45 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT, 2025
FIGURE 46 B. BRAUN SE: COMPANY SNAPSHOT, 2025
FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT, 2025
FIGURE 48 PENUMBRA, INC.: COMPANY SNAPSHOT, 2025
FIGURE 49 STRYKER CORPORATION: COMPANY SNAPSHOT, 2025
FIGURE 50 RESEARCH DESIGN
FIGURE 51 PRIMARY SOURCES
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 55 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 56 BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE ANALYSIS (2025)
FIGURE 57 PERIPHERAL VASCULAR DEVICES MARKET: SUPPLY-SIDE ANALYSIS
FIGURE 58 TOP-DOWN APPROACH
FIGURE 59 CAGR PROJECTIONS FROM ANALYSIS OF PERIPHERAL VASCULAR DEVICES MARKET DYNAMICS, 2026-2031
FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF PERIPHERAL VASCULAR DEVICES MARKET, 2026-2031
FIGURE 61 DATA TRIANGULATION